1. Home
  2. TNYA vs HYI Comparison

TNYA vs HYI Comparison

Compare TNYA & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

SELL

Current Price

$0.54

Market Cap

153.2M

Sector

Health Care

ML Signal

SELL

Logo Western Asset High Yield Defined Opportunity Fund Inc.

HYI

Western Asset High Yield Defined Opportunity Fund Inc.

HOLD

Current Price

$9.71

Market Cap

135.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNYA
HYI
Founded
2016
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
153.2M
135.2M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
TNYA
HYI
Price
$0.54
$9.71
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $3.20
N/A
AVG Volume (30 Days)
★ 2.6M
68.0K
Earning Date
11-09-2026
01-01-0001
Dividend Yield
N/A
★ 9.59%
EPS Growth
★ 54.96
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$9.61
52 Week High
$2.35
$11.61

Technical Indicators

Market Signals
Indicator
TNYA
HYI
Relative Strength Index (RSI) 29.52 27.95
Support Level $0.53 N/A
Resistance Level $0.82 $10.66
Average True Range (ATR) 0.03 0.12
MACD -0.01 -0.02
Stochastic Oscillator 12.65 16.05

Price Performance

Historical Comparison
TNYA
HYI

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

About HYI Western Asset High Yield Defined Opportunity Fund Inc.

Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.

Share on Social Networks: